Kwality Pharmaceuticals

Kwality Pharmaceuticals EBIT per Share

The EBIT per Share of Kwality Pharmaceuticals (539997.BO) as of Nov 5, 2026 is 59.85 INR. In the previous year, EBIT per Share was 45.09 INR — a change of 32.71% (higher).

EBIT per Share

59.85INR

YoY

32.71%

Last updated:

EBIT per Share of Kwality Pharmaceuticals is 2025 59.85 INR. EBIT per Share of Kwality Pharmaceuticals was 2024 45.09 INR. It decreases by 32.71% higher compared to the previous year.

The Kwality Pharmaceuticals EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
8.36 INR
Jan 1, 2019
12.13 INR
Jan 1, 2020
9.41 INR
Jan 1, 2021
21.55 INR
Jan 1, 2022
155.14 INR
Jan 1, 2023
43.54 INR
Jan 1, 2024
45.09 INR
Jan 1, 2025
59.85 INR
The Kwality Pharmaceuticals EBIT per Share history
YEAREBIT per ShareYoY
59.85INR+32.71%
45.09INR+3.56%
43.54INR-71.93%
155.14INR+620.05%
21.55INR+129.01%
9.41INR-22.45%
12.13INR+45.03%
8.36INR+37.40%
6.09INR+66.27%
3.66INR+87.64%
1.95INR+74.19%
1.12INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kwality Pharmaceuticals Stock analysis

What does Kwality Pharmaceuticals do? Kwality Pharmaceuticals Pvt Ltd manufactures pharmaceutical formulations including liquid orals, powders for oral suspension, tablets, capsules, sterile injections, ointments, and oral rehydration solutions. The company produces drugs in categories such as beta lactam, hormones, cytotoxic oncology, and effervescent. It handles customized business as per client requirements and has 48 production sections across its facilities. Kwality exports its products to Europe, Africa, and Asia, with registered products in these regions. The company operates as a manufacturer, buyer, and seller of pharmaceutical intermediates, chemicals, extracts, alkaloids, and medical preparations. It deals in drug intermediates, chemicals, and other pharmaceutical goods alongside toilet requisites and beverages. Kwality's business model focuses on exporting formulations to international markets, particularly targeting regions where its registered products are approved for sale. Kwality Pharmaceuticals serves as a manufacturer and distributor for pharmaceutical products, catering to global markets through its registered product portfolio. The firm's production capabilities include sterile powders for injections, small volume injectables, and external preparations, supporting diverse medical needs across different regions. Kwality Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kwality Pharmaceuticals stock

EBIT per Share of Kwality Pharmaceuticals is 59.85 INR in 2025.

EBIT per Share of Kwality Pharmaceuticals changed from 45.09 INR to 59.85 INR, representing a 32.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Kwality Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Kwality Pharmaceuticals

All Key Metrics — Kwality Pharmaceuticals